In coeliac disease, there is an increase in passive intestinal permeability to large polar molecules, ranging in size from proteins' down to oligosaccharides. In contrast, small polar molecules are malabsorbed. We have described34 our preliminary findings using a test of intestinal permeability (known as the cellobiose/mannitol test or 'sugar test' for short), based on the simultaneous oral administration and five-hour urinary recoveries of two probe molecules. The larger molecule used was cellobiose, a disaccharide (molecular radius 5A), and the smaller was mannitol, a polyhydric alcohol (molecular radius 4A). We showed that untreated coeliacs absorbed significantly more cellobiose, and less mannitol than control patients, and, when the result was expressed as a ratio (cellobiose recovery/ mannitol recovery), the discrimination was greatly enhanced. We postulated that, by expressing the result in this way, the sensitivity of the test as a screening procedure would be increased, and that, providing the two molecules were not too dissimilar
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Received for publication 4 December 1979 in their behaviour, the influence of extraneous factors such as renal impairment would be eliminated or at least minimised. This would appear to be the case; certainly, patients with renal failure or liver disease have ratios within normal limits, and there is no significant correlation between values for the ratio and those for the serum creatinine, gastric emptying, or intestinal transit times5.
This paper describes the test results in a variety of gastrointestinal conditions, and compares the diagnostic accuracy and sensitivity of the test with other screening procedures for coeliac disease.
Methods

CELLOBIOSE/MANNITOL TEST
Technique
The test solution comprised 5 g cellobiose and 2 g mannitol dissolved in 100 ml water, to which were added 20 g lactose and 20 g sucrose to render the solution hypertonic (c. 1500 mOsmol). This has been shown to enhance the absorption of the larger molecule and increase the discrimination between controls and coeliacs,25 the use of two sugars being dictated by considerations of solubility and palata-bility. The solution was drunk after fasting overnight and urine collected for five hours. Cellobiose and mannitol were assayed as previously described,3 the results being expressed as the percentage recoveries of the two molecules in five hours. The ratio was derived from the absolute recoveries (in milligrams) -that is, cellobiose recovery (mg)/mannitol recovery (mg).
Patients
Tests were carried out by both hospital patients and outpatients at home. The following groups were studied.
Controls
Fifty-five control patients were identified who had performed the test, had had a normal jejunal biopsy, and in whom no significant gastrointestinal pathology was found on further investigation. Nineteen were referred with severe oral aphthae, four with unexplained anaemia, and two were relatives of known coeliacs. The remaining 30 presented with various combinations of diarrhoea, weight loss, and abdominal pain for which no cause was found. Many were diagnosed as suffering from the irritable bowel syndrome, on the basis of the negative tests and symptomatic response to highfibre diet. group.bmj.com on May 4, 2017 -Published by http://gut.bmj.com/ Downloaded from partial gastrectomy and two had had a vagotomy and gastroenterostomy: patients with small bowel contamination were not included in this group, having already been counted in the previous group. Five patients had had a normal jejunal biopsy.
Untreated coeliacs
Hypolactasia
Two patients had primary hypolactasia, the diagnosis being based on lactase assay of a biopsy in one, and on a lactose/hydrogen breath test7 in the other. Both had appropriate symptoms and a normal jejunal biopsy.
Proctitis/colitis Ten patients with idiopathic proctitis or classical ulcerative colitis were studied. Three patients with a proctitis had had a normal jejunal biopsy at some stage in their investigations.
Crohn's disease Fifteen patients had Crohn's disease. In seven the most proximal involvement radiologically was in the terminal ileum, while eight had evidence of disease in the jejunum or proximal ileum.
COMPARISON WITH OTHER SCREENING TESTS
Ninety-eight patients were identified who had had a jejunal biopsy and had carried out the test. This total comprised 24 patients with villous atrophy and 74 with normal histology (55 controls, plus 19 with other conditions) (see above). Of the patients with villous atrophy 15 had had a standard 5 g xylose tolerance test (12 assessed by five hour urine recovery, three by a one hour blood level) and 18 were investigated for the presence of reticulin antibodies in their serum. Serum folate was measured in 21 and red-cell folate in 15.
Of the patients with normal biopsies, 24 had carried out a xylose test (21 urine, three blood), reticulin antibodies had been sought in 45, serum folate measured in 47, and red-cell folate in 38.
A xylose recovery of less than 24% in five hours, or a blood level below 1 30 mmol/l were regarded as abnormal by the chemical pathology department. A serum folate of over 5.0 ,ug/l was considered to be normal, and less than 4.0,ug/1 abnormal, by the Haematology Department. A borderline value The possible explanations for the paradoxical behaviour of the two probe molecules in coeliac disease have been discussed in previous publications.3 Similar mechanisms probably apply in Crohn's disease, which is known to be associated with both malabsorption and an increased transepithelial leakage of protein. 8 The results of the test in Crohn's disease demonstrate this, but also indirectly confirm that the test mainly reflects changes in proximal intestinal function. It has been used to follow the response to a gluten-free diet,4 and it is interesting to consider the results in one patient with jejunal Crohn's disease and an abnormal ratio, who was studied serially before and after a small bowel resection: his initial postoperative improvement and later recrudescence of disease were reflected by corresponding changes in the test ratio.5
As a screening test for coeliac disease, it would appear to be very sensitive and specific. The only false-negative result was in a man who had dermatitis herpetiformis and who was otherwise totally asymptomatic: no other screening test was abnormal. The one false-positive result was not confirmed on repeat testing, and the reason for it is unknown. We have generally found the ratio to be reproducible in the same subject (Fig. 4) . It could have been a labelling or dilutional error in one of the assays: we do not consider it as evidence that the test result is altered after gastric surgery, but we have counted it as a false-positive result for the purposes of comparison.
When considering screening tests for a disease, what matters to a clinician is how much reliance he can place on the result, and it is possible to be misled as to the value of a test if the study does not take into account the actual incidence of the disease in the population which it is wished to screen. For example, to compare results in equal numbers of control and diseased patients would be wrong, if in practice the diagnosis was confirmed in only a small Five control subjects and four untreated coeliacs repeated the test as shown. Although there was variation between individual cellobiose and mannitol recoveries in the same subject, the ratio was much more reproducible.
percentage of those suspected of having the disease. Excluding two coeliacs from other hospitals whom we were kindly allowed to study, this means that 96 patients presented to us in whom we felt that a jejunal biopsy was indicated, and that 22 of these (23%) had villous atrophy. A review of our previous biopsy figures showed that approximately 18% of biopsies were found to be abnormal: this suggests that the 96 patients represent a genuine population for screening, and that our indications for performing a biopsy were not greatly influenced by the study. The poor showing of the urinary xylose test is in keeping with the findings of others.910 One hour blood xylose tests have been claimed to be much more accurate,1' although this has been denied by others.'2 Recently, the correlation of one hour blood xylose with body surface area has produced very promising results,13 and it may be that the blood xylose would have proved to be as discriminating as the cellobiose/mannitol ratio. It is unlikely to be much better, particularly as, of the six one-hour blood xylose results incorporated into the figures, five correctly predicted the biopsy findings, but one was a false-positive. The serum folate fared little better than the urine xylose test and would probably have made a much worse showing if borderline results had not been given the benefit of the doubt. Red-cell folate was better, but still significantly worse than the cellobiose/mannitol ratio. Reticulin antibodies proved to be highly specific, with only one false-positive, but were absent in a number of patients with villous atrophy. Of the 13 patients in whom gluten sensitivity has been confirmed histo. logically, at least six had no detectable reticulin antibodies. This is a rather lower incidence than was found by Mallas and his colleagues'4 (about 80%); their results in control patients (not biopsied) were similar to ours-1/56 false-positive, but they did detect antibodies in over 25% of normal relatives of coeliacs, producing a much higher false-positive rate.
The cellobiose/mannitol ratio is abnormal in some cases of proximal Crohn's disease, and, clearly, if these results are taken as false-positives, the specificity of the test for coeliac disease is reduced. On the other hand, it might be considered an advantage, in that it would draw the attention of the clinician to the small bowel as the source of a patient's symptoms. The correct diagnosis would then be fairly simply made on radiological or histological grounds. Reticulin antibodies may be more specific, and would be less likely to be abnormal in these patients, but would almost certainly be less accurate in screening asymptomatic coeliac relatives, for example.
It is probably more important for a screening test to be sensitive rather than specific, as the consequences of failing to pick up a case are usually more serious than a misdiagnosis, which will be corrected by the appropriate confirmatory test. We would naturally anticipate that, as the numbers studied increase, the boundary between the cellobiose/mannitol ratios for controls and coeliacs will in time become more blurred. However, it should be noted that 51 of our 55 controls had ratios of 0.07 or less, and only four were between 008 and 0.10. In the future, therefore, it might prove advantageous to lower the upper limit of normal in order to pick up more coeliacs. This should not greatly increase the number of false-positive results, although even a corrected normal range-for example, 0-008-would still have misdiagnosed our one coeliac patient with a low ratio (0.05).
In conclusion, the cellobiose/mannitol test assesses two aspects of proximal intestinal permeability. We have found it to be more sensitive, and at least as specific as other screening tests for coeliac disease.
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